Aquestive Therapeutics (AQST) EBT Margin Growth (1y) (2018 - 2026)
Aquestive Therapeutics (AQST) EBT Margin Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | 342.00 |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | -166.00 |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -1,258.00 |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | 2,773.00 |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | 1,800.00 |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | 132.00 |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | -16,509.00 |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | 1,555.00 |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | 127,245.00 |
| 10 | Aquestive Therapeutics | 515.58 Mn | 404.84 Mn | 10.98 Mn | 20,719.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20,719.00 |
| Dec 31, 2025 | 24,798.00 |
| Sep 30, 2025 | -3,562.00 |
| Jun 30, 2025 | -12,178.00 |
| Mar 31, 2025 | -15,653.00 |
| Dec 31, 2024 | -8,318.00 |
| Sep 30, 2024 | -6,826.00 |
| Jun 30, 2024 | 2,794.00 |
| Mar 31, 2024 | -17,889.00 |
| Dec 31, 2023 | 5,498.00 |
| Sep 30, 2023 | 9,263.00 |
| Jun 30, 2023 | 16,218.00 |
| Mar 31, 2023 | 18,021.00 |
| Dec 31, 2022 | 14,565.00 |
| Sep 30, 2022 | 18.00 |
| Jun 30, 2022 | 41,458.00 |
| Mar 31, 2022 | 7,566.00 |
| Dec 31, 2021 | -668.00 |
| Sep 30, 2021 | 30,423.00 |
| Jun 30, 2021 | -15,155.00 |